The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
That said, um if you want to consider inflammaging, >> you know, to be an underlying condition in a lot of people's aging, then you could say that eight randomized clinical trials showing beneficial effects of NR in lowering inflammation could be broadly useful for for human aging.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
do I think there's a use case for Niogen in people in healthy aging yes on the basis of eight randomized clinical trials showing anti-inflammatory benefits in people positive trial and peripheral artery disease and some of these suggestively positive trials like long co which which we talked about